Mounjaro®
Starting from £179.99/mo
Start journey Learn moreWhen you stop taking Wegovy, appetite typically returns within days to a few weeks, and without the hormonal signal that was reducing hunger, many people regain a significant portion of the weight they lost. Clinical evidence and the NHS semaglutide guidance are both clear on this: semaglutide works while it is active in your body, and the effects reverse once treatment ends. That is not a failure on your part. It reflects the biology of how GLP-1 medicines work and, importantly, how obesity itself works as a long-term condition — one that does not resolve the moment the pen goes in the bin. Understanding what to expect, and what choices are available to you, is the most useful thing you can do before or after stopping.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Semaglutide has a half-life of roughly a week, so it clears gradually rather than abruptly. For the first few days after your last dose, you may notice little difference. Then, typically in the second or third week, hunger comes back with more force than you may remember, partly because your stomach empties faster again, and partly because the brain signals that semaglutide was dampening are no longer being overridden.
A practical thing worth doing in this window: weigh yourself on the same scales, at the same time of day, once a week, and write it down. Not to catastrophise small fluctuations, but to have honest data. Early, slow regain is much easier to discuss with a prescriber than a year-long drift that has already compounded.
Some people also notice their energy levels shift. During treatment, lower calorie intake sometimes means lower energy in the first weeks; after stopping, appetite increases before eating patterns do, so there is a brief period of adjustment. GI symptoms that troubled you at the start of treatment (nausea, loose stools) largely do not return when you stop. If you have a query about what is normal for your specific situation, our FAQs cover common concerns, and prescriber support is available seven days a week.
The STEP 1 trial, published in the New England Journal of Medicine, included a 20-week follow-up period after participants stopped semaglutide 2.4mg. On average, participants regained about two-thirds of their lost weight within that window, and cardiometabolic improvements, including blood pressure and blood glucose changes, also partially reversed. That is the honest picture, and it matters.
What the evidence does not show is that stopping treatment causes harm in itself, or that the weight lost during treatment was wasted. Many people use a course of treatment alongside genuine changes to their diet and activity levels, and those habits can slow the rate of regain considerably. The NHS healthy weight guidance describes the dietary and movement patterns that support weight maintenance; they do not require perfection, but they do require consistency.
People who stopped because of side effects, cost, or a planned pause rather than a deliberate end to treatment may have different outcomes than those who completed a full course. If cost is part of the decision, it is worth reading about what a private prescription service includes before assuming treatment has to stop entirely.
Stopping Wegovy is not an irreversible decision. Semaglutide can be restarted from the lowest dose if there has been a gap, subject to a fresh clinical assessment. That is true whether you stopped for a few weeks or several months. A prescriber would review your current weight, any changes to your health since your last consultation, and whether Wegovy remains the most appropriate option for you. Our Wegovy information page covers the full eligibility picture for the injection if you are considering returning to it.
Some people stopping Wegovy are interested in whether other injectable options might suit them better, or whether tirzepatide (a dual GIP and GLP-1 receptor agonist) is worth discussing. Others want to understand whether the full range of weight-loss treatments now available in the UK includes something better matched to their needs. These are clinical conversations, not things to navigate from a search engine alone.
If you stopped because of a planned surgical procedure, pregnancy, or a medical contraindication, your prescriber should be the one guiding when and whether it is appropriate to return to treatment. The same applies if you are considering stopping to try to conceive: semaglutide is not recommended during pregnancy or breastfeeding, and your prescriber can advise on the wash-out period and contraception guidance before any change.
NICE's recommendation for semaglutide (Wegovy) via NHS services specifies a maximum treatment period of two years, within a specialist service. Private prescribing follows the licensed indications in the SmPC rather than the NICE NHS-access criteria, but the underlying point stands: Wegovy is not assumed to be indefinite for every person, and clinical review along the way is how that gets assessed rather than assumed.
If you are approaching the end of a treatment course, or you have already stopped and are noticing the pattern described above, a conversation with a prescriber is the right next move. Our clinical team reviews consultations personally, a real clinician reads your answers on the same day you submit them. If you stopped treatment elsewhere and want a second opinion on restarting or switching, find out how we work before deciding. For anything more urgent or specific to your health, your GP remains your first port of call.
The fuller picture of what happens when you stop taking Wegovy, including the physiological detail, is covered on the what happens to your body when you stop taking Wegovy page. And if the gap in treatment has been around two weeks rather than longer, the considerations are somewhat different, see what happens if you stop taking Wegovy for two weeks for that specific scenario. When you are ready to speak to a prescriber, start your free consultation at any point, and if you want to look further ahead, the page on what happens after you stop Wegovy sets out what to expect over the longer term, while what happens when you stop taking Wegovy for weight loss explores how discontinuing treatment affects your progress specifically in that context.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.